The clinic was established in 1991 and is the main centre for patients
with HTLV-1 & HTLV-2 infection in the United Kingdom.
The aim of the service:
• To assess, treat and manage patients with HTLV infection.
• To offer counselling for patients with HTLV infection and their families.
• To investigate why and how some patients with HTLV infection develop the disease.
• To study and improve the treatment of patients with HTLV associated disease.
Other services include:
• Pre-test information
• Diagnostic tests and specialised investigations
• Specialist multidisciplinary management of HTLV-associated diseases
• Long-term follow up of HTLV carriers
• Patient information and support
• Advice on pregnancy and infant feeding
• Research studies
• Clinical trials
Covid-19 advice for those
living with HTLV infection
In order to best support people living with HTLV infection during the Covid-19 pandemic, we have considered advice from both Public Health England (PHE) and Imperial College Healthcare NHS Trust.
This is a new virus, and there are no data yet on how it will affect those living with HTLV infection.
For those with HTLV-2 infection we do not expect any impact of Covid 19 on this.
For those with HTLV-1, low proviral load (less than 4%) and asymptomatic infection, the risk may be the same as for those without HTLV infection and advice from the NHS and government for the general population applies.
The National Centre for Human Retrovirology Clinic Imperial College Healthcare NHS Trust, Ground Floor, Winston Churchill Wing, St Mary's Hospital, Praed Street, London W2 1NY